Porous EH and EH-PEG scaffolds as gene delivery vehicles to skeletal muscle

Pharmaceutical Research

Volumn 28, Issue 6, 2011, Pages 1306-1316

  Falco, Erin E ^a   Wang, Martha O ^a   Thompson, Joshua A ^a   Chetta, Joshua M ^a   Yoon, Diana M ^b   Li, Erik Z ^a   Kulkami, Mangesh M ^c   Shah, Sameer ^a   Pandit, Abhay ^c   Roth, J Scott ^d   Fisher, John P ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b Rice University   (United States)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

cyclic acetal; gene therapy; IGF 1; synthetic meshes

Indexed keywords

5 ETHYL 5 (HYDROXYMETHYL) BETA,BETA DIMETHYL 1,3 DIOXANE 2 ETHANOL DIACRYLATE; GREEN FLUORESCENT PROTEIN; MOLECULAR SCAFFOLD; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA CLEAVAGE; DRUG RELEASE; FLUORESCENCE ACTIVATED CELL SORTING; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; POROSITY; PRIORITY JOURNAL; SKELETAL MUSCLE; VIRAL GENE DELIVERY SYSTEM;

ACRYLATES; BIOCOMPATIBLE MATERIALS; CELLS, CULTURED; DRUG CARRIERS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; PLASMIDS; POLYMERS; POROSITY; RECOMBINANT FUSION PROTEINS; REGENERATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 79959877733     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0358-5     Document Type: Article

References (29)

1. F Delieand MJ Blanco-Prieto 2005 Polymeric particulates to improve oral bioavailability of peptide drugs Molecules 10 65 80 10.3390/10010065 (Pubitemid 40404886)
2. AS Hoffman 1995 "Intelligent" polymers in medicine and biotechnology Artif Organs 19 458 467 7625927 10.1111/j.1525-1594.1995.tb02359.x 1:CAS:528:DyaK2MXmt1OitL4%3D
3. IY Galaevand B Mattiasson 1999 'Smart' polymers and what they could do in biotechnology and medicine Trends Biotechnol 17 335 340 10.1016/S0167-7799(99) 01345-1 (Pubitemid 29342314)
4. Breen A, O'Brien T, Pandit A. Fibrin as a delivery system for therapeutic drugs and biomolecules. Tissue Eng Part B Rev. 2009;15(2):201-14.
5. EE Falco M Patel JP Fisher 2008 Recent developments in cyclic acetal biomaterials for tissue engineering applications Pharm Res 25 2348 2356 18536870 10.1007/s11095-008-9620-5 1:CAS:528:DC%2BD1cXhtFOru7zL
6. J Raghunath J Rollo KM Sales PE Butler AM Seifalian 2007 Biomaterials and scaffold design: key to tissue-engineering cartilage Biotechnol Appl Biochem 46 73 84 17227284 10.1042/BA20060134 1:CAS:528:DC%2BD2sXitlSqurY%3D
7. A Lendlein K Kratz S Kelch 2005 Smart implant materials Med Device Technol 16 12 14 15871417 1:STN:280:DC%2BD2M3js1KrtQ%3D%3D
8. E Sachlosand JT Czernuszka 2003 Making tissue engineering scaffolds work. Review: the application of solid freeform fabrication technology to the production of tissue engineering scaffolds Eur Cell Mater 5 29 39 discussion 39-40
9. Moreau JL, Kesselman D, Fisher JP. Synthesis and properties of cyclic acetal biomaterials. J Biomed Mater Res A. 2006.
10. S Kaihara S Matsumura JP Fisher 2007 Synthesis and properties of Poly[poly(ethylene glycol)-co-cyclic acetal] based hydrogels Macromolecules 40 7625 7632 10.1021/ma071297p 1:CAS:528:DC%2BD2sXhtVWrsLjM (Pubitemid 350014290)
11. L Nair C Laurencin 2007 Biodegradable polymers as biomaterials Prog Polym Sci 32 762 798 10.1016/j.progpolymsci.2007.05.017 1:CAS:528: DC%2BD2sXovFeksL0%3D (Pubitemid 47198287)
12. S Kaihara S Matsumura JP Fisher 2008 Synthesis and characterization of cyclic acetal based degradable hydrogels Eur J Pharm Biopharm 68 67 73 17888640 10.1016/j.ejpb.2007.05.019 1:CAS:528:DC%2BD2sXhsVSgtbrE (Pubitemid 350186237)
13. EE Falco JS Roth JP Fisher 2008 EH Networks as a scaffold for skeletal muscle regeneration in abdominal wall hernia repair J Surg Res 149 76 83 18395749 10.1016/j.jss.2007.08.016 1:CAS:528:DC%2BD1cXhtVShsb%2FI
14. MW Betz PC Modi JF Caccamese DP Coletti JJ Sauk JP Fisher 2008 Cyclic acetal hydrogel system for bone marrow stromal cell encapsulation and osteodifferentiation J Biomed Mater Res A 86 662 670 18022839
15. S Braun 2008 Muscular gene transfer using nonviral vectors Curr Gene Ther 8 391 405 18855634 10.2174/156652308786070998 1:CAS:528:DC%2BD1cXhsFemt7%2FL
16. Y Lee EJ Park SS Yu DK Kim S Kim 2000 Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles: implication for gene therapy of ischemic diseases Biochem Biophys Res Commun 272 230 235 10872832 10.1006/bbrc.2000.2758 1:CAS:528:DC%2BD3cXkt1ansbk%3D (Pubitemid 30444927)
17. A Musarò C Giacinti G Borsellino G Dobrowolny L Pelosi L Cairns, et al. 2004 Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1 Proc Natl Acad Sci USA 101 1206 14745025 10.1073/pnas.0303792101 (Pubitemid 38182667)
18. DL DeVol P Rotwein JL Sadow J Novakofski PJ Bechtel 1990 Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth Am J Physiol 259 E89 95 2372054 1:CAS:528:DyaK3cXlt1OisLg%3D
19. F Beguinot CR Kahn AC Moses RJ Smith 1985 Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells J Biol Chem 260 15892 15898 2999143 1:CAS:528:DyaL2MXlvFSmtr8%3D (Pubitemid 16169368)
20. ER Barton-Davis DI Shoturma HL Sweeney 1999 Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle Acta Physiol Scand 167 301 305 10632630 10.1046/j.1365-201x.1999.00618.x 1:CAS:528:DC%2BD3cXlt1aruw%3D%3D (Pubitemid 30037871)
21. F Mourkiotiand N Rosenthal 2005 IGF-1, inflammation and stem cells: interactions during muscle regeneration Trends Immunol 26 535 542 10.1016/j.it.2005.08.002 (Pubitemid 41297684)
22. N Hashimoto T Murase S Kondo A Okuda M Inagawa-Ogashiwa 2004 Muscle reconstitution by muscle satellite cell descendants with stem cell-like properties Development 131 5481 5490 15469979 10.1242/dev.01395 1:CAS:528:DC%2BD2cXhtVCjs7fE (Pubitemid 39562190)
23. GR Adamsand SA McCue 1998 Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats J Appl Physiol 84 1716 1722 (Pubitemid 28225913)
24. ER Barton-Davis DI Shoturma A Musaro N Rosenthal HL Sweeney 1998 Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function Proc Natl Acad Sci USA 95 15603 15607 9861016 10.1073/pnas.95.26.15603 1:CAS:528:DyaK1MXhvFejtA%3D%3D (Pubitemid 29018746)
25. C Thomas A Ehrhardt M Kay 2003 Progress and problems with the use of viral vectors for gene therapy Nat Rev Genet 4 346 358 12728277 10.1038/nrg1066 1:CAS:528:DC%2BD3sXjtlaksr4%3D (Pubitemid 36538359)
26. Vermaand I, Weitzman M. Gene therapy: twenty-first century medicine. Biochemistry. 2005;74:711-38. (Pubitemid 40995522)
27. Grunwaldand S, Speer A. Efficient transfection of primary human skeletal myoblasts using FuGENE® HD transfection reagent. Gene Expr. 2007;3:26.
28. A Arnold V Laporte S Dumont A Appert-Collin P Erbacher G Coupin, et al. 2006 Comparing reagents for efficient transfection of human primary myoblasts: FuGENE 6, Effectene and ExGen 500 Fundam Clin Pharmacol 20 81 89 16448398 10.1111/j.1472-8206.2005.00344.x 1:CAS:528:DC%2BD28XitVajsLk%3D
29. L Ye H Haider W Esa P Law W Zhang L Su, et al. 2007 Nonviral vector-based gene transfection of primary human skeletal myoblasts Exp Biol Med (Maywood, NJ) 232 1477 10.3181/0706-RM-175 1:CAS:528:DC%2BD2sXhsVahsbnP (Pubitemid 350220547)